Skip to content

Author

P. Dibajnia

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

The Combination of Atezolizumab and Bevacizumab Versus Lenvatinib as a First-Line Systemic Therapy for Treatment of Hepatocellular Carcinoma: A Real-World Comparison

Introduction: Atezolizumab plus bevacizumab (AB) and lenvatinib (LEN) demonstrate non-inferior survival compared with sorafenib for first-line treatment of unresectable hepatocellular carcinoma (HCC) but have not been directly compared. We retrospectively compared survival outcomes between patients treated with AB and...

K. Jobin, M. Hannouf, Mark Freeman et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.